ACORN CAPITAL ADVISORS, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0002054410 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 17, 2026

Total Value: $295M (100.0% shares, 0.0% debt)

Holdings (21)

TERN TERNS PHARMACEUTICALS INC 23.9%
Value $70.55M Shares 1,746,264 Est. Cost $6.77 Unrealized +241.3%
CGON CG ONCOLOGY INC 15.9%
Value $46.98M Shares 1,131,501 Est. Cost $34.21 Unrealized +21.0%
URGN UROGEN PHARMA LTD 11.5%
Value $33.92M Shares 1,448,420 Est. Cost $13.24 Unrealized +63.9%
TRVI TREVI THERAPEUTICS INC 9.1%
Value $26.85M Shares 2,144,844 Est. Cost $3.31 Unrealized +249.6%
PBYI PUMA BIOTECHNOLOGY INC 8.3%
Value $24.58M Shares 4,131,299 Est. Cost $2.92 Unrealized +81.7%
CADL CANDEL THERAPEUTICS INC 4.9%
Value $14.58M Shares 2,580,517 Est. Cost $5.97 Unrealized -9.9%
HELP CYBIN INC 4.4%
Value $12.87M Shares 1,573,023 Est. Cost $8.17 Unrealized -21.2%
VSTM VERASTEM INC 3.8%
Value $11.34M Shares 1,469,153 Est. Cost $6.27 Unrealized +42.1%
BCAX BICARA THERAPEUTICS 3.7%
Value $10.83M Shares 643,382 Est. Cost $20.81 Unrealized -17.9%
TARA PROTARA THERAPEUTICS INC 3.2%
Value $9.339M Shares 1,752,115 Est. Cost $3.29 Unrealized +69.0%
OKUR ONKURE THERAPEUTICS INC 2.8%
Value $8.235M Shares 2,839,674 Est. Cost $8.97 Unrealized -66.6%
CRDF CARDIF ONCOLOGY INC 1.9%
Value $5.513M Shares 1,962,084 Est. Cost $3.02 Unrealized -23.2%
LONA ATHIRA PHARMA INC. 1.3%
Value $3.798M Shares 501,739 Est. Cost $4.58 Unrealized 0.0%
JSPR JASPER THERAPEUTICS 1.1%
Value $3.269M Shares 1,786,492 Est. Cost $2.80 Unrealized -28.3%
AURA AURA BIOSCIENCES INC 1.1%
Value $3.247M Shares 595,744 Est. Cost $7.57 Unrealized -21.5%
WHWK WHITEHAWK THERAPEUTICS INC 0.9%
Value $2.757M Shares 1,139,363 Est. Cost $2.27 Unrealized +1.3%
BCAB BIOATLA INC 0.9%
Value $2.756M Shares 4,835,111 Est. Cost $1.47 Unrealized -46.6%
QTTB Q32 BIO INC. 0.6%
Value $1.638M Shares 493,425 Est. Cost $31.58 Unrealized -91.0%
X4 PHARMACEUTICALS INC 0.4%
Value $1.093M Shares 273,349 Est. Cost $1.91 Unrealized
ACRV ACRIVON THERAPEUTICS INC 0.3%
Value $977K Shares 405,237 Est. Cost $7.27 Unrealized -70.1%
VYNE VYNE THERAPEUTICS INC 0.0%
Value $827 Shares 1,425 Est. Cost $2.55 Unrealized -84.3%